Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
Elias Othman, Assistant Professor at Volgograd State Medical University, shared a post on LinkedIn:
“Can an enzyme involved in cell signaling become a target for antithrombotic drug discovery?
One of the research areas that has interested me is the search for new approaches to antithrombotic therapy.
We often think about thrombosis in terms of platelets and the coagulation cascade.
But drug discovery can also begin by asking a different question:
What intracellular pathways influence platelet function and thrombus formation?
One interesting target is glycogen synthase kinase-3 beta (GSK-3β), a multifunctional enzyme involved in several cellular signaling pathways.
In our research, we investigated 3-arylidene-2-oxindole derivatives as potential GSK-3β inhibitors and explored their antithrombotic properties.
What I find particularly interesting about this type of research is the journey:
- Molecular target
- Design and evaluation of compounds
- Pharmacological mechanism
- Effect on thrombosis
- Potential for future drug development
Of course, discovering a promising compound is only the beginning.
A finding from experimental research does not automatically mean that a new medicine is ready for patients.
There are many steps between target validation and clinical application.
That gap between a biological mechanism and a potential therapy is what makes drug discovery so fascinating to me.
What molecular target do you think has the most interesting potential for future antithrombotic drug development?”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention